Literature DB >> 9172168

Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function.

M Vanhanen1, K Koivisto, L Karjalainen, E L Helkala, M Laakso, H Soininen, P Riekkinen.   

Abstract

We studied cognitive function in normoglycaemic elderly subjects at different risk levels for developing non-insulin-dependent diabetes mellitus (NIDDM) and in patients with NIDDM. Risk for NIDDM was considered increased if both 2 h glucose and insulin values on oral glucose tolerance testing were higher than the median in normoglycaemic subjects, and low if the respective values were lower than the median. The increased risk group showed impairment on tests of immediate and delayed memory, attention, visuomotor speed and verbal fluency. Moreover, the increased risk group did not differ from patients with NIDDM on any cognitive tests. Our results suggest that increased risk for NIDDM is associated with widely affected cognitive function in the normoglycaemic elderly, highlighting the importance of healthy living habits.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9172168     DOI: 10.1097/00001756-199704140-00041

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  20 in total

1.  High normal fasting blood glucose is associated with dementia in Chinese elderly.

Authors:  James A Mortimer; Amy R Borenstein; Ding Ding; Charles Decarli; Qianhua Zhao; Cathleen Copenhaver; Qihao Guo; Shugang Chu; Douglas Galasko; David P Salmon; Qi Dai; Yougui Wu; Ronald Petersen; Zhen Hong
Journal:  Alzheimers Dement       Date:  2010-11       Impact factor: 21.566

2.  Are neurocognitive speed and inconsistency similarly affected in type 2 diabetes?

Authors:  Bonnie P Whitehead; Roger A Dixon; David F Hultsch; Stuart W S MacDonald
Journal:  J Clin Exp Neuropsychol       Date:  2011-07       Impact factor: 2.475

3.  Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease.

Authors:  Laura D Baker; Laura L Frank; Karen Foster-Schubert; Pattie S Green; Charles W Wilkinson; Anne McTiernan; Brenna A Cholerton; Stephen R Plymate; Mark A Fishel; G Stennis Watson; Glen E Duncan; Pankaj D Mehta; Suzanne Craft
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults.

Authors:  Amber S Watts; Natalia Loskutova; Jeffrey M Burns; David K Johnson
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Septal co-infusions of glucose with the benzodiazepine agonist chlordiazepoxide impair memory, but co-infusions of glucose with the opiate morphine do not.

Authors:  Desiree L Krebs-Kraft; Marise B Parent
Journal:  Physiol Behav       Date:  2009-12-22

6.  Aging, vascular risk, and cognition: blood glucose, pulse pressure, and cognitive performance in healthy adults.

Authors:  Cheryl L Dahle; Bradley S Jacobs; Naftali Raz
Journal:  Psychol Aging       Date:  2009-03

7.  Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly.

Authors:  Antonio Convit; Oliver T Wolf; Chaim Tarshish; Mony J de Leon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

8.  C-reactive protein is linked to lower cognitive performance in overweight and obese women.

Authors:  V Sweat; V Starr; H Bruehl; A Arentoft; A Tirsi; E Javier; A Convit
Journal:  Inflammation       Date:  2008-03-18       Impact factor: 4.092

Review 9.  Diabetes, sugar-coated but harmful to the brain.

Authors:  Vanessa L Starr; Antonio Convit
Journal:  Curr Opin Pharmacol       Date:  2007-11-19       Impact factor: 5.547

10.  Zero net flux estimates of septal extracellular glucose levels and the effects of glucose on septal extracellular GABA levels.

Authors:  Desiree L Krebs-Kraft; Gail Rauw; Glen B Baker; Marise B Parent
Journal:  Eur J Pharmacol       Date:  2009-04-01       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.